Pharma industry is growing very fast mainly through the inorganic route and given below are some major deals in last five years. RanbaxySun TOP PHARMA DEALS IN INDIA Target Acquirer Deal Size ($bn) Year Ranbaxy Daiichi...
Aurobindo in last lap to buy Mallinckrodt’s US generics business
Aurobindo Pharma is in final negotiations to acquire Mallinckrodt’s specialty generics business in the US—including its portfolio of opioid-based painkillers—for $850-900 million after talks resumed in May, said...
Aurobindo eyes Mallinckrodt Opioids Again
Even as the Donald Trump administration intensifies its crackdown on the opioid crisis in the US, homegrown Aurobindo PharmaNSE -0.50 % has re-engaged with Mallinckrodt to acquire its specialty generics portfolio. But...
Hyderabad’s Aurobindo in race to buy Novartis’ generic dermatology business
After Ahmedabad’s Torrent Pharmaceuticals dropped the idea to acquire Sanofi’s European generic business last month, Hyderabad-headquartered Aurobindo Pharma is in the race to buy the dermatology generics...
Aurobindo launches $1.6 billion bid to buy Novartis generics unit
Aurobindo Pharma Ltd has submitted an initial bid to buy Novartis AG’s dermatology generics drug business for about $1.6 billion, two people directly aware of the development said on condition of anonymity. Hyderabad...
Torrent Pharma may raise Rs1,500 crore in bid for Sanofi generics business
Torrent Pharma Ltd is likely to raise at least Rs1,500 crore by selling shares to institutional investors, as it prepares a bid for the generic drugs unit of France’s Sanofi, two people aware of the development said...
Torrent Pharma readies €2 billion binding offer for Sanofi’s European unit
Torrent Pharmaceuticals Ltd is readying a €2 billion (Rs16,000 crore) bid for Zentiva N.V., the generic drugs unit of France’s Sanofi, two people directly aware of the bidding process said. If Ahmedabad-based Torrent is...
Intas closing in on Mallinckrodt’s US generics business
Intas Pharmaceuticals, backed by Temasek and ChrysCapital, has inched closer to arguably the biggest cross-border buyout by an Indian pharma company, emerging as the front-runner to acquire Mallinckrodt’s generics drug...
Aurobindo Pharma, Intas in race for Teva’s European assets
Aurobindo Pharma Ltd and Intas Pharmaceuticals Ltd are in the race to acquire part of the European assets of Israeli generic drugmaker Teva Pharmaceutical Industries Ltd in a deal that, if completed, could be the...
Lupin says looking at buyout opportunities in domestic market
Mumbai: After a series of acquisitions in overseas markets over the past two years, Lupin Ltd is looking at buyout opportunities in the domestic market to gain market share, said a top executive. These could be either...
With an aim of expansion, pharma companies like Lupin and Torrent eyeing overseas acquisition
MUMBAI: India’s top pharmaceutical companies are set to embark on an acquisition spree to bulk up their overseas presence. LupinBSE 0.60 %, Torrent, ZydusBSE -0.05 % Cadila, Intas, AurobindoBSE 1.34 %, Dr...
Outbound M&A deals rose last year, but restricted to a few sectors
Overseas acquisitions by Indian companies have picked up again, after a brief lull, although deal activity this time is restricted to companies from cash-rich sectors such as information technology and pharmaceuticals...